# Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC

> **NCT00259675** · PHASE2 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 100 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** carboplatin/gemcitabine, carboplatin/taxol

## Key facts

- **NCT ID:** NCT00259675
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2007-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259675, "Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00259675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*